JPRN-jRCT2080220477
Unknown
Phase 3
A study to evaluate the effects of human lymphoblastoid interferon (HLBI) in hepatitis C patients with compensated cirrhosis.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Chronic hepatitis C with compensated cirrhosis
- Sponsor
- Dainippon Sumitomo Pharma Co., Ltd.
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\-Compensated cirrhosis patients
- •\-Patients aged 20 to less than 76
- •\-Patients with chronic liver diseases except chronic hepatitis C with compensated cirrhosis, such as autoimmune hepatitis, alcoholic hepatitis, and drug\-induced liver injury.
- •\-Decompensated cirrhosis patients
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Evaluation of lymphocyte therapy effects on treatment of women with unexplained Recurrent Spontaneous Abortion (RSA)Recurrent spontaneous abortion.(O31.1)IRCT20201126049497N2Birjand University of Medical Sciences50
Completed
Not Applicable
Study about outcomes of Lymph-drainage for human legs.Healthy peopleJPRN-UMIN000024657Graduate school of Health Sciences, Kumamoto University10
Not yet recruiting
Not Applicable
Exploratory clinical study of lymphatic and blood flow evaluation by indocyanine-green fluorescence imaging in esophageal cancer operatioEsophageal cancer patient whose assigned to surgical treatmentJPRN-UMIN000030165niversity of Tokyo Hospital19
Recruiting
Phase 2
yophilized human amniotic membrane; a dressing for chronic diabetic foot wound healingDiabetic foot ulcer.E11IRCT20190131042570N1Stem Cell and Regenerative Medicine Research Center18
Recruiting
Not Applicable
Study for the lymphatic function before and afterlymph node dissection for gynecological cancerSecondary LymphedemaJPRN-UMIN000008313Chiba University50